Should patients with hepatic fibrosis undergo LVAD implantation: A comparative analysis

Linnea Xuereb, Pauline H. Go, Babbaljeet Kaur, Silvy Akrawe, Jamil Borgi, Gaetano Paone, Jeffrey A. Morgan

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

The purpose of our study was to evaluate outcomes in patients with hepatic fibrosis at the time of LVAD implantation. There were five (2.1%) patients with preoperative hepatic fibrosis with a mean age of 51.2 ± 16.8 years. Survival at 180 days was significantly reduced in patients with hepatic fibrosis, 40.0% vs. 88.0%; p = 0.001. Hepatic fibrosis was a significant independent predictor of mortality in multivariate analysis (hazard ratio [HR] 2.27, p = 0.036).

Original languageEnglish (US)
Pages (from-to)498-500
Number of pages3
JournalASAIO Journal
Volume62
Issue number4
DOIs
StatePublished - Aug 1 2016

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Biomedical Engineering

Fingerprint Dive into the research topics of 'Should patients with hepatic fibrosis undergo LVAD implantation: A comparative analysis'. Together they form a unique fingerprint.

Cite this